Neurobiological Technologies Announces Update Call on Viprinex (TM) Phase 3 Trial Program
October 10 2008 - 4:00PM
PR Newswire (US)
EMERYVILLE, Calif., Oct. 10 /PRNewswire-FirstCall/ --
Neurobiological Technologies, Inc. (NTI(R)) (NASDAQ:NTII), today
announced it will hold a conference call on Monday, October 13, to
provide an update on the Viprinex(TM) (ancrod) Phase 3 Trial
Program for acute ischemic stroke. Hosting the call will be Paul E.
Freiman, president and chief executive officer and Warren W.
Wasiewski, chief medical officer. -- Date: Monday, October 13, 2008
-- Time: 1:00 p.m. (ET), 12:00 p.m. (CT), 10:00 a.m. (PT) --
Dial-in number: 877-440-5803 U.S. & Canada / 719-325-4942
International Telephonic Replay: A playback of the conference call
will be available from 1:00 p.m. (ET) on October 13, 2008 to
midnight (ET) on October 20, 2008. Replay number: 888-203-1112 U.S.
/ 719-457-0820 International Pass code: 9164451 About
Neurobiological Technologies, Inc. Neurobiological Technologies,
Inc., (NASDAQ:NTII) is a biopharmaceutical company focused on
developing novel, first-in-class agents for central nervous system
conditions and other serious unmet medical needs. The Company's
most advanced product candidate, Viprinex(TM) (ancrod), is in Phase
3 clinical testing as a novel investigational drug for the
treatment of acute ischemic stroke. Viprinex has multiple
mechanisms of action and is specifically designed to extend the
time period that patients can be treated after the onset of a
stroke. Acute ischemic stroke is one of the most prevalent,
debilitating and costly diseases in the world for which there are
few acceptable treatment options. NTI also has early-stage
development programs for Alzheimer's and Huntington's diseases and
rights to receive payments on an approved drug for Alzheimer's
disease and an investigational drug in Phase 3 trials for brain
swelling. DATASOURCE: Neurobiological Technologies, Inc. CONTACT:
Matthew M. Loar, CFO of Neurobiological Technologies, Inc.,
+1-510-595-6000 Web site: http://www.ntii.com/
Copyright
Neurobiological (NASDAQ:NTII)
Historical Stock Chart
From Aug 2024 to Sep 2024
Neurobiological (NASDAQ:NTII)
Historical Stock Chart
From Sep 2023 to Sep 2024